The new KATALYST-AV trial, sponsored by Kardigan, Inc aims to evaluate whether the investigational medication ataciguat can slow the buildup of calcium in the aortic valve in adults with moderate calcific aortic valve stenosis (CAVS).
Thursday, January 8, 2026
Sarasota Memorial’s Kolschowsky Research and Education Institute is now enrolling patients in the international KATALYST-AV trial, which is testing the first potential therapy to treat calcium build up in the aortic valve, rather than just managing symptoms. The study is being led locally by interventional cardiologist Ricardo Yayura, MD. Calcific Aortic Valve Disease (CAVD) is increasing worldwide, with severe cases requiring valve replacement for survival.
Thursday, January 8, 2026
If you smoke tobacco, the greatest change you can make for your health this year is to quit. Here are some tips and resources to get you started, straight from the healthcare professionals who see the impact of smoking—and quitting—firsthand.
Monday, January 5, 2026
SMH is among the first wave of U.S. hospitals offering renal denervation, a minimally invasive outpatient procedure to treat people with high blood pressure that does not respond to conventional medications and lifestyle therapies.
Friday, January 2, 2026
Sarasota Memorial Health Care System rang in the New Year by welcoming the first babies of 2026 at both its Sarasota and Venice campuses in the early hours of Jan. 1.
Thursday, January 1, 2026